You are here: Industry Insights > colorectal cancer

News List

News of Note—A drug to reduce age-related stomach damage; a CAR-T to attack colon tumors fiercebiotech
May 08, 2018
Scientists at the Massachusetts Institute of Technology have discovered in mouse experiments that a decline in intestinal stem cells that typically occurs during aging can be reversed with 24 hours of fasting...
Roche Halts Colorectal Cancer Trial Recruitment After 4 Patient Deaths biospace
April 12, 2018
Roche announced it had temporarily halted recruiting patients to its Phase II MODUL clinical trial for metastatic colorectal cancer after four patient deaths
APAC colorectal cancer therapeutics market to reach $8 bn by 2023 expressbpd
August 07, 2017
Growth will be driven by the expected approval of promising therapies
Researchers publish new findings on influence of high-fat diet on colorectal cancer worldpharmanews
July 10, 2017
Poor diet is associated with 80% of colorectal cancer cases, but the exact pathways by which diet leads to cancer are not known. In a newly published study,
First patients treated in Phase I/II trial of NOX-A12 combined with Keytruda in metastatic pancreati cphi-online
July 06, 2017
NOX-A12 has the potential to transform cancer types that are resistant to checkpoint inhibitor therapy into checkpoint inhibitor sensitive tumours
Bristol-Myers Squibb announces new collaboration to evaluate combination therapy in colorectal cance worldpharmanews
June 06, 2017
Bristol-Myers Squibb Company (NYSE:BMY) announced today it has entered into a clinical research collaboration with Novartis to investigate the safety, tolerability and efficacy of Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen in combination
Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe en-cphi.cn
April 28, 2017
Volition (NYSE MKT: VNRX) has commenced its first study in Asia - an evaluation of the Nu.QTM Colorectal Cancer Triage product in a Taiwan, Chinaese population of 383 subjects.
Colorectal cancer on the increase among youths, experts warn pharmanewsonline
March 30, 2017
Findings by members of the American Cancer Society, have indicated four times increase in the risk of the condition among adolescents than the elderly.
NICE expands reach of Erbitux in colorectal cancer pharmatimes
March 03, 2017
Cost regulators for the NHS treatments in England and Wales are expanding the scope of Merck's Erbitux so that
Owlstone Medical commences 1,400 patient clinical trial for early detection of colorectal cancer pharmaasia
February 13, 2017
World’s largest breath-based study into colorectal (bowel) cancer will be run in collaboration with the University of Warwick and the University Hospital Coventry and Warwickshire NHS Trust.

Previous page 1 2 3 Next page